Skip to main content
SpringerLink
Log in

Medical Needs

  • Chapter
Contrast-Enhanced Ultrasound of Liver Diseases

  • 168 Accesses

Abstract

Due its relative low cost, safety and availability, conventional ultrasound (US) remains the most widely used cross-sectional imaging modality in routine clinical practice worldwide. Recent advances in nonlinear imaging together with a whole new generation of echo-enhancing agents have improved the clinical applications of US. Indeed there are now increasing reports of single-and multicenter studies confirming improved detection and characterization of focal liver lesions with contrast-enhanced US (Albrecht et al. 2001; Bernatik et al. 2001; Needleman et al. 2000; Wilson et al. 2000; Leen et al. 2002a). In a study comparing unenhanced versus contrast-enhanced US in the detection of liver metastases, the average number of confirmed metastases increased from 3.06 to 5.42 following contrast administration; the sensitivity for detecting individual metastases significantly improved from 63% to 91 %.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albrecht T, Hoffmann CW, Schmitz SA, et al (2001) Phase inversion sonography during the liver specific late phase of contrast enhancement: improved detection ofliver metastases. AJR 176:1191–1198

    Article  Google Scholar 

  • Albrecht T, Blomley MKJ, Burns PN, et al (2002) Improved detection of hepatic metastases with pulse inversion ultrasonography during the liver specific phase of SHU 508A(Levovist) - a multi-centre study. Radiology (in press)

    Google Scholar 

  • Ballantyne GH (1993) Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71:4252–4266

    Article  Google Scholar 

  • Benvegnu L, Fattovich G, Noventa, et al (1994) Concurrent hepatitis Band C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 74:2442–2448

    Google Scholar 

  • Bernatik T, Strobel D, Hahn EG, Becker D (2001) Detection of liver metastases. Comparison of contrast enhanced wide band harmonic imaging with conventional ultrasonography. J Ultrasound Med 20:509–515

    CAS  Google Scholar 

  • Biggs CG, Ballantyne GH (1994) Sensitivity versus cost effectiveness in post operative follow-up for colorectal cancer. Curr Opnion Gen Surg 94–102

    Google Scholar 

  • Bosch FX, Ribes J (2000) Epidemiology of liver cancer in Europe. Can J Gastroenterol 14:621–30

    Google Scholar 

  • Bruix J, Sherman M, Llovet JM, et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-EASL Conference. J Hepatol. 35:421–430

    Google Scholar 

  • Clarke MR, Kane RA, Steele G Jr, et al (1989) Prospective comparison of pre-operative imaging and intraoperative ultrasonography in the detection of liver tumours. Surgery 106:849–855

    Google Scholar 

  • Colombo M, De Franchis R, Del Ninno E, et al (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. Lancet 325:675–680

    Google Scholar 

  • El-Serag HB, Mason AC (2000) Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160:3227–3230

    Article  Google Scholar 

  • Fargion S, Fracanzani AL, Piperno A, et al (1994) Prognostic factors for hepatocellular carcinoma in genetic haemochromatosis. Hepatology 10:1426–1431

    Article  Google Scholar 

  • Foster ME, Hill J, Leaper DJ (1987) Follow-up after colorectal cancer-current practice in Wales and South West England. Int J Colorectal Dis 2:118–119

    Article  Google Scholar 

  • Freeny PC (1988) Hepatic CT: state of the art. Radiology 168:319–323

    Google Scholar 

  • Howell JD, Wotherspoon H, Leen E, et al (1999) Evaluation of a follow-up programme after curative resection for colorectal cancer. Br J Cancer 79:308–310

    Article  Google Scholar 

  • Jones DE, Metcalf JV, Collier JD, Bassendine MF, James OF (1997) Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology 26:1138–1142

    Article  Google Scholar 

  • Jones EC, Chezmar JL, Nelson RC, Bernardino ME (1992) The frequency and significance of small (less than or equal 15mm) hepatic lesions detected by CT. AJR 158:535–539

    Article  Google Scholar 

  • Karhunen PJ (1986) Benign hepatic tumours and tumour like conditions in men. J Clin Pathol 39:183–188

    Article  PubMed  CAS  Google Scholar 

  • Karhunen PJ, Penttila A (1987). Pre-neoplastic lesions of human liver. Hepatogastroenterology 34:10–15

    Google Scholar 

  • Leen E, Correas JM, Needleman L, et al (2002a) Multicentre study of Sonazoid enhanced sonography of patients with known primary cancer: improved detection ofliver metastases. (Abstract) Radiology (in press)

    Google Scholar 

  • Leen E, Angerson WJ, Yarmenitis S, et al (2002b) Multicentre clinical study evaluating the efficacy of SonoVue in Doppler investigation of focal hepatic lesions. Eur J Radiol 41:200–206

    Article  Google Scholar 

  • Mella J, Datta SN, Biffin A, et al (1997) Surgeons follow-up practice after resection of colorectal cancer. Ann R Coli Surg England 79:206–209

    Google Scholar 

  • Needleman L, Leen E, Kyriakopoulou K, et al (2000) NC100100, a new liver specific contrast agent for fundamental and harmonic imaging of hepatic lesions. (Abstract) Radiology 209:189

    Google Scholar 

  • Nordic Gastrointestinal Tumour Adjuvant Therapy Group (1992) Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer; a randomised trial. J Clin Oncol 10:904–911

    Google Scholar 

  • Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S (1994) Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 19:61–66

    Google Scholar 

  • Pateron D, Ganne N, Trinchet JC, et al (1994) Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 20:65–71

    Article  Google Scholar 

  • Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM (1999) Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 210:71–74

    Google Scholar 

  • Sherman M, Peltekian KM, Lee C (1995) Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 22:432–438

    Google Scholar 

  • Sheu JC, Chen DS, Sung JL, et al (1985) Hepatocellular carcinoma in the early stage. Radiology 155:463–467

    Google Scholar 

  • Wilson SR, Burns PN, Muradali D, et al (2000) Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterisation of haemangioma, hepatocellular carcinoma and metastasis. Radiology 215:153–161

    Google Scholar 

  • Zaman SN, Johnson PJ, Williams R (1990) Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high incidence and low incidence areas. Cancer 65:1607–1610

    Article  Google Scholar 

  • Zoli M, Magolotti D, Bianchi G, Gueli C, Marchenisi G, Pisa E (1996) Efficacy. of surveillance program for early detection of hepatocellular carcinoma. Cancer 78:977–985

    Article  Google Scholar 

Download references

Authors
  1. E. Leen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Italia

About this chapter

Cite this chapter

Leen, E. (2003). Medical Needs. In: Contrast-Enhanced Ultrasound of Liver Diseases. Springer, Milano. https://doi.org/10.1007/978-88-470-2093-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2093-1_5

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2168-6

  • Online ISBN: 978-88-470-2093-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation